John J. Crowley

Insider Reports History

Location
Cheshire, United Kingdom
Signature
/s/ Raphael Deferiere, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John J. Crowley:

Company Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Chief Financial Officer Ordinary Shares 45,000 $1,125,450 $25.01 02 Feb 2026 Direct
Fusion Pharmaceuticals Inc. Chief Financial Officer Common Stock 0 $0 $2.03 04 Jun 2024 Direct
Fusion Pharmaceuticals Inc. Chief Financial Officer Restricted Stock Units 0 $0 $2.03 04 Jun 2024 Direct
Centessa Pharmaceuticals plc Chief Financial Officer Share Option (right to buy) 181,000 02 Feb 2026 Direct
Fusion Pharmaceuticals Inc. Chief Financial Officer Stock Option (Right to Buy) 0 04 Jun 2024 Direct

Insider Reports Filed by John J. Crowley

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTA Centessa Pharmaceuticals plc 02 Feb 2026 2 $0 4 Chief Financial Officer 03 Feb 2026, 19:02
CNTA Centessa Pharmaceuticals plc 03 Feb 2025 1 $0 4 Chief Financial Officer 04 Feb 2025, 16:57
CNTA Centessa Pharmaceuticals plc 01 Jul 2024 1 $0 4 Chief Financial Officer 02 Jul 2024, 16:30
CNTA Centessa Pharmaceuticals plc 10 Jun 2024 0 $0 3 Chief Financial Officer 17 Jun 2024, 20:49
/report/000095017024068893-crowley-john-j-2024-06-04 Fusion Pharmaceuticals Inc. 04 Jun 2024 10 $0 4 Chief Financial Officer 04 Jun 2024, 17:26
/report/000095017024002299-crowley-john-j-2024-01-04 Fusion Pharmaceuticals Inc. 04 Jan 2024 2 $0 4 Chief Financial Officer 05 Jan 2024, 08:52
/report/000120919123002496-crowley-john-j-2023-01-05 Fusion Pharmaceuticals Inc. 05 Jan 2023 1 $0 4 Chief Financial Officer 09 Jan 2023, 05:44
/report/000120919122007050-crowley-john-j-2022-02-01 Fusion Pharmaceuticals Inc. 01 Feb 2022 2 $0 4 Chief Financial Officer 03 Feb 2022, 18:37